Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
about
siRNA and RNAi optimizationOligonucleotide Therapies: The Past and the PresentIn Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs DeliveryFusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.Multifunctional RNA nanoparticles.siRNAmod: A database of experimentally validated chemically modified siRNAsTriggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applicationsDesign of siRNA Therapeutics from the Molecular ScaleAdvances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection.Advances in targeted delivery of small interfering RNA using simple bioconjugates.Functional peptides for siRNA delivery.RNA/aTNA chimeras: RNAi effects and nucleases resistance of single and double stranded RNAs.Exosomes are natural carriers of exogenous siRNA to human cells in vitro.Intracellular Reassociation of RNA-DNA Hybrids that Activates RNAi in HIV-Infected Cells.Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the BrainSMEpred workbench: A web server for predicting efficacy of chemicallymodified siRNAs.Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand.RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.Amide linkages mimic phosphates in RNA interactions with proteins and are well tolerated in the guide strand of short interfering RNAs.Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy.
P2860
Q26769738-DC26CD32-E4B4-4175-97BD-47A4CB141320Q27002403-81414A7A-D3C5-4098-AB3D-3F8538BB530CQ30538383-C125CBF5-72C3-4A22-8454-14CD6D042B3DQ31137535-254199AE-EEE1-4ED2-BAF0-D6A29E76333FQ34080235-2B6713FB-C798-4D3E-9128-63F5D8F1799FQ34306130-084233C6-1B34-4205-8933-F05B91449F3BQ34511095-362AACF2-074C-4A0E-A9B5-B53B3E97D043Q35027155-9C7583D5-EDDE-4ADE-97A0-403A4914D581Q36449335-7EB5A415-F730-432E-B4C9-CCEF534F95C5Q37111734-9C33F730-BF6F-4B9E-A12E-663733351645Q38144256-71C50A2E-9A58-4054-83CB-A59CC760DFB1Q38199518-E45E17E8-28DF-453C-9D35-76234438FC88Q38928987-683D867A-71FF-4013-B0CD-08E87E9EAC32Q38942269-388C36D7-27E9-4E86-B0E7-ABEFA98B73C6Q39061886-B26E8B6A-E8C9-44DC-A59E-17DAF8DE5DBCQ40113804-40D6AE3F-3520-42B0-85A5-999FBC8BF9F1Q41810449-270B81F1-B3A0-43C3-9ADF-AE2987FDDECBQ42123815-A5E1782F-302F-4D89-B7C2-6EC81FE08AB7Q42288252-D28B2C49-84B4-460F-BC18-633F78D5767BQ45871459-0E95E36B-178F-4483-8970-2F586A81AEAEQ47222077-4207B62D-955B-4B67-BACE-F8596ACE6D66Q52618071-622D703B-7448-41BA-8222-90CE037CE342
P2860
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@ast
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@en
type
label
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@ast
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@en
prefLabel
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@ast
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@en
P2860
P356
P1476
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.
@en
P2093
Jesper B Bramsen
Jørgen Kjems
P2860
P356
10.3389/FGENE.2012.00154
P577
2012-08-20T00:00:00Z